Table 1.
Variable group | Measures | Source of measures | |
A | IPV exposure | Ever physical, sexual, emotional Past year, postrape |
WHO multi-country study instrument61 (tested in South Africa by Jewkes et al)62 |
B | Rape circumstances and physical trauma/injuries | Rape circumstances: number of perpetrators, relationship to perpetrator, weapon use, degree of violence, type of rape Intimidation by the perpetrator or friends |
Jewkes et al63
(Questions to be asked after criminal case have been closed) |
C | Rape stigma and social support | Rape stigma and self-blame Coping mechanisms Rape disclosure Social support Social disruption: leaving home, school, relationship |
Social Support Appraisal Scale64; Brief COPE65; South African Stigma Scale66 |
D | Demographic factors | Demographic factors: age, income, education, employment, relationship status, sexual orientation | Jewkes et al62 |
E | Mental health outcomes | Depression Anxiety disorders PTSD Suicidality Other anxiety disorders Alcohol and drug abuse Cortisol level in hair Epigenetic changes Telomere length |
MINI for psychosis and anxiety disorders49; CES-D (depression)67; AUDIT (alcohol)68; DUDIT (drugs)68–70; Life Events Checklist71; Davidson Trauma Scale (PTSD)72 73
Cortisol in hair and epigenetics analysis from blood samples |
F | Other trauma | Previous trauma: child abuse, other interpersonal violence or traumatic life events Follow-up interview: rape, interpersonal violence or traumatic life events since the last interview |
Childhood trauma scale Bernstein et al74 modified for South Africa Jewkes et al75
Life Events Checklist; rape and forced sex measures from Jewkes et al62 |
G | Criminal justice processes and circumstances of the rape | Case progression: case dropped, arrest, bail, guilty plea, case withdrawn, trial commenced, testimony in court given, trial outcome Perceived satisfaction with the system including information given about whereabouts of accused |
Jewkes et al63; satisfaction questions to be developed (These questions will be asked once criminal case have been closed.) |
H | Acquiescence to male domination of sex | Attitudes to gender relations and perceived social norms Consistent condom use Relationship control scale Sexual frequency |
Jewkes et al62; attitudes developed in South Africa and validated in Jewkes et al76 |
I | Own sexual risk behaviour | Transactional sex Partner numbers ever and past year Concurrency |
Jewkes et al62 75 |
J | Partner riskiness | STIs of current partner Use of IPV by current partner Partners’ concurrency/polygamy |
Jewkes et al62 4 |
K | Biological risk enhancers or co-factors | Hormonal contraception use at baseline and ongoing Pregnancy loss (since last interview): termination, miscarriage |
Questions from the Demographic and Health Survey77 |
L | Cardio-metabolic risk assessment | Screening questions for risk assessment Measurements: hip and waist, BP, BMI, glucose status (glycaemia/Hba1c) and lipid panels CRP ultrasensitive (cardiac), Gamma-GT, ALT (SGPT), AST (SGOT), creatinine (serum), |
Questions from the WHO STEPs questionnaire78 |
M | Healthcare seeking practices postrape health, HIV testing and adherence | Completion of PEP and STI treatment Emergency contraception HIV testing postrape and previously HIV disclosure Attendance for health assessment Commencement of ART and adherence Experience of HIV-related ill-health Satisfaction with healthcare provision |
Items developed and tested in pilot |
O | Reproductive and child health | Contraception, fertility, pregnancies, reproductive health Child health including babies born during RICE study participation |
Questions developed and adapted from Demographic and Health Survey |
ALT, alanine aminotransferase; ART, antiretroviral therapy; AST, aspartate aminotransferase; AUDIT, Alcohol Use Disorders Identification Test; BMI, body mass index; BP, blood pressure; CES-D, Center for Epidemiologic Studies Depression Scale; CRP, C-reactive protein; DUDIT, Drug Use Disorders Identification Test; IPV, intimate partner violence; MINI, Mini International Neuropsychiatric Interview; PEP, postexposure prophylaxis; PTSD, post-traumatic stress disorder; RICE, Rape Impact Cohort Evaluation; SGOT, serum glutamic oxaloacetic transaminase; SGPT, serum glutamic pyruvic transaminase; STI, sexually transmitted infection.